![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: WNT2 |
Gene summary for WNT2 |
![]() |
Gene information | Species | Human | Gene symbol | WNT2 | Gene ID | 7472 |
Gene name | Wnt family member 2 | |
Gene Alias | INT1L1 | |
Cytomap | 7q31.2 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P09544 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7472 | WNT2 | S027 | Human | Liver | HCC | 9.45e-26 | 1.70e+00 | 0.2446 |
7472 | WNT2 | S028 | Human | Liver | HCC | 1.59e-44 | 1.65e+00 | 0.2503 |
7472 | WNT2 | S029 | Human | Liver | HCC | 3.68e-62 | 2.66e+00 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0071496111 | Esophagus | ESCC | cellular response to external stimulus | 215/8552 | 320/18723 | 4.29e-15 | 2.43e-13 | 215 |
GO:0031668111 | Esophagus | ESCC | cellular response to extracellular stimulus | 168/8552 | 246/18723 | 4.93e-13 | 2.23e-11 | 168 |
GO:0031669110 | Esophagus | ESCC | cellular response to nutrient levels | 148/8552 | 215/18723 | 4.58e-12 | 1.76e-10 | 148 |
GO:0031667111 | Esophagus | ESCC | response to nutrient levels | 289/8552 | 474/18723 | 9.25e-12 | 3.47e-10 | 289 |
GO:001605517 | Esophagus | ESCC | Wnt signaling pathway | 268/8552 | 444/18723 | 2.32e-10 | 6.58e-09 | 268 |
GO:019873817 | Esophagus | ESCC | cell-cell signaling by wnt | 269/8552 | 446/18723 | 2.41e-10 | 6.79e-09 | 269 |
GO:0009267110 | Esophagus | ESCC | cellular response to starvation | 110/8552 | 156/18723 | 2.63e-10 | 7.37e-09 | 110 |
GO:004259419 | Esophagus | ESCC | response to starvation | 133/8552 | 197/18723 | 4.31e-10 | 1.14e-08 | 133 |
GO:00163316 | Esophagus | ESCC | morphogenesis of embryonic epithelium | 98/8552 | 147/18723 | 2.12e-07 | 3.27e-06 | 98 |
GO:0061458110 | Esophagus | ESCC | reproductive system development | 247/8552 | 427/18723 | 2.24e-07 | 3.42e-06 | 247 |
GO:004860818 | Esophagus | ESCC | reproductive structure development | 245/8552 | 424/18723 | 2.82e-07 | 4.14e-06 | 245 |
GO:006007016 | Esophagus | ESCC | canonical Wnt signaling pathway | 180/8552 | 303/18723 | 9.15e-07 | 1.17e-05 | 180 |
GO:00303239 | Esophagus | ESCC | respiratory tube development | 112/8552 | 181/18723 | 7.82e-06 | 7.69e-05 | 112 |
GO:006056210 | Esophagus | ESCC | epithelial tube morphogenesis | 187/8552 | 325/18723 | 9.95e-06 | 9.44e-05 | 187 |
GO:00605417 | Esophagus | ESCC | respiratory system development | 123/8552 | 203/18723 | 1.26e-05 | 1.15e-04 | 123 |
GO:00303249 | Esophagus | ESCC | lung development | 109/8552 | 177/18723 | 1.40e-05 | 1.27e-04 | 109 |
GO:00604257 | Esophagus | ESCC | lung morphogenesis | 37/8552 | 50/18723 | 4.42e-05 | 3.51e-04 | 37 |
GO:00604414 | Esophagus | ESCC | epithelial tube branching involved in lung morphogenesis | 22/8552 | 29/18723 | 9.30e-04 | 4.73e-03 | 22 |
GO:00016559 | Esophagus | ESCC | urogenital system development | 177/8552 | 338/18723 | 7.51e-03 | 2.69e-02 | 177 |
GO:20000274 | Esophagus | ESCC | regulation of animal organ morphogenesis | 71/8552 | 125/18723 | 7.97e-03 | 2.84e-02 | 71 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
WNT2 | FZD6_LRP5 | WNT2_FZD6_LRP5 | WNT | Endometrium | ADJ |
WNT2 | FZD4_LRP6 | WNT2_FZD4_LRP6 | WNT | Endometrium | ADJ |
WNT2 | FZD6_LRP6 | WNT2_FZD6_LRP6 | WNT | Endometrium | ADJ |
WNT2 | FZD4_LRP6 | WNT2_FZD4_LRP6 | WNT | Endometrium | AEH |
WNT2 | FZD4_LRP6 | WNT2_FZD4_LRP6 | WNT | Endometrium | EEC |
WNT2 | FZD6_LRP6 | WNT2_FZD6_LRP6 | WNT | Endometrium | EEC |
WNT2 | FZD10_LRP6 | WNT2_FZD10_LRP6 | WNT | Esophagus | ESCC |
WNT2 | FZD3_LRP6 | WNT2_FZD3_LRP6 | WNT | Esophagus | ESCC |
WNT2 | FZD4_LRP6 | WNT2_FZD4_LRP6 | WNT | Esophagus | ESCC |
WNT2 | FZD5_LRP6 | WNT2_FZD5_LRP6 | WNT | Esophagus | ESCC |
WNT2 | FZD6_LRP6 | WNT2_FZD6_LRP6 | WNT | Esophagus | ESCC |
WNT2 | FZD8_LRP6 | WNT2_FZD8_LRP6 | WNT | Esophagus | ESCC |
WNT2 | FZD4_LRP5 | WNT2_FZD4_LRP5 | WNT | HNSCC | OSCC |
WNT2 | FZD6_LRP5 | WNT2_FZD6_LRP5 | WNT | HNSCC | OSCC |
WNT2 | FZD6_LRP6 | WNT2_FZD6_LRP6 | WNT | HNSCC | OSCC |
WNT2 | FZD6_LRP5 | WNT2_FZD6_LRP5 | WNT | HNSCC | Precancer |
WNT2 | FZD6_LRP6 | WNT2_FZD6_LRP6 | WNT | HNSCC | Precancer |
WNT2 | FZD1_LRP5 | WNT2_FZD1_LRP5 | WNT | THCA | Cancer |
WNT2 | FZD4_LRP5 | WNT2_FZD4_LRP5 | WNT | THCA | Cancer |
WNT2 | FZD6_LRP5 | WNT2_FZD6_LRP5 | WNT | THCA | Cancer |
Page: 1 2 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
WNT2 | SNV | Missense_Mutation | c.689N>A | p.Thr230Lys | p.T230K | P09544 | protein_coding | deleterious(0) | possibly_damaging(0.903) | TCGA-55-A490-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | SD | |
WNT2 | SNV | Missense_Mutation | c.197N>T | p.Ser66Ile | p.S66I | P09544 | protein_coding | deleterious(0) | benign(0.093) | TCGA-L9-A443-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
WNT2 | SNV | Missense_Mutation | c.896G>T | p.Arg299Leu | p.R299L | P09544 | protein_coding | tolerated(0.27) | benign(0.053) | TCGA-18-3409-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
WNT2 | SNV | Missense_Mutation | novel | c.152N>T | p.Gln51Leu | p.Q51L | P09544 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-56-7580-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
WNT2 | SNV | Missense_Mutation | rs180913783 | c.791N>T | p.Thr264Met | p.T264M | P09544 | protein_coding | deleterious(0.01) | probably_damaging(0.954) | TCGA-60-2703-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
WNT2 | SNV | Missense_Mutation | c.503N>T | p.Ala168Val | p.A168V | P09544 | protein_coding | deleterious(0) | possibly_damaging(0.457) | TCGA-66-2759-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Chemotherapy | carboplatin | CR | |
WNT2 | SNV | Missense_Mutation | c.663N>C | p.Trp221Cys | p.W221C | P09544 | protein_coding | deleterious(0) | possibly_damaging(0.861) | TCGA-66-2793-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
WNT2 | SNV | Missense_Mutation | novel | c.131N>C | p.Val44Ala | p.V44A | P09544 | protein_coding | deleterious(0) | possibly_damaging(0.489) | TCGA-98-A53B-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
WNT2 | SNV | Missense_Mutation | novel | c.474N>A | p.Ser158Arg | p.S158R | P09544 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-CN-5360-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | SD |
WNT2 | SNV | Missense_Mutation | novel | c.943N>C | p.Thr315Pro | p.T315P | P09544 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CR-6472-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |